Netris Revenue and Competitors
Estimated Revenue & Valuation
- Netris's estimated annual revenue is currently $7.2M per year.
- Netris's estimated revenue per employee is $240,000
Employee Data
- Netris has 30 Employees.
- Netris grew their employee count by 7% last year.
Netris's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Account Manager | Reveal Email/Phone |
Netris Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.2M | 7 | -12% | $22M | N/A |
#2 | $64M | 194 | 7% | N/A | N/A |
#3 | $5.3M | 25 | -4% | N/A | N/A |
#4 | $5M | 24 | 26% | $24.2M | N/A |
#5 | $5.3M | 25 | -4% | N/A | N/A |
#6 | $10.8M | 45 | -4% | N/A | N/A |
#7 | $16.5M | 61 | -2% | N/A | N/A |
#8 | $10.3M | 47 | N/A | N/A | N/A |
#9 | $14.4M | 55 | -11% | $82.8M | N/A |
#10 | $4.2M | 20 | -5% | N/A | N/A |
What Is Netris?
Netris is the new automatic netops. Netris enables customers to operate their physical/private networks like a cloud. We are headquartered in Santa Clara, California, with a globally distributed team. Our customers are trusting up to 100% of their production networks to Netris - the automatic netops.
keywords:N/A
N/A
Total Funding
30
Number of Employees
$7.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Netris News
Array BioPharma Inc, AstraZeneca Plc, Daiichi Sankyo Company Ltd, Handok Inc, Ignyta Inc, Loxo Oncology Inc, Netris Pharma SAS, Plexxikon Inc.
Using our top-of-the-class IIoT device NETRIS® and our user-friendly cloud dashboard Oil Link, our customers have been able to quickly...
KANKAKEE-Netris Tietz, 69, of Kankakee, Illinois, went to her eternal home on Friday, March 4, 2022. She is survived by 3 daughters: Shona (...
Other Companies in Santa Clara
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.2M | 30 | 0% | N/A |
#2 | $7.8M | 30 | 20% | N/A |
#3 | $4.7M | 30 | -23% | $27.2M |
#4 | $3.4M | 30 | N/A | N/A |
#5 | $3.2M | 30 | -35% | $146M |